Capecitabine in the treatment of esophageal and gastric cancers

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.12, 2013-12, pp. : 1645-1657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Modality Therapy of Localized Gastric and Esophageal Cancers

By Das Prajnan Fukami Norio Ajani Jaffer A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 4, 2006-04 ,pp. : 375-382

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1678-1682

Bentham Science Publishers

Access to resources Recommend Favorite

The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers

Journal of Digestive Diseases, Vol. 16, Iss. 5, 2015-05 ,pp. : 256-263

John Wiley & Sons Inc

Access to resources Recommend Favorite

Capecitabine in advanced gastric cancer

By Okines Alicia Chau Ian Cunningham David

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2851-2861

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine/mitomycin effective in gastrointestinal cancers

Inpharma, Vol. 1, Iss. 1461, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite